Thryve Wealth Management’s Merck MRK Stock Holding History

Thryve Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,206	Closed	-$232K	–	75
2025 Q4	$232K	Buy	+2,206	New	+$207K	0.11%	87

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Thryve Wealth Management's MRK Position: Q1 2026 in Review

Thryve Wealth Management sold out of Merck (MRK) in Q1 2026, closing a stake of 2,206 shares — an estimated $232K sold.

Thryve Wealth Management first reported a position in MRK in Q4 2025 and held it in 1 quarter. The position peaked at $232K in Q4 2025. 3,796 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Thryve Wealth Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
Thryve Wealth Management sold 2,206 Merck shares in Q1 2026, an estimated $232K.
Thryve Wealth Management first reported a position in Merck in Q4 2025 and held it in 1 quarter.
Thryve Wealth Management's Merck position peaked at $232K in Q4 2025.
3,796 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Thryve Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.